Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

UPDATE 1-Canada to send army, Red Cross to province worst affected by COVID-19 surge

Published 2021-04-26, 07:21 p/m

(Recasts with federal help for Ontario, Alberta vaccination plans)

OTTAWA, April 26 (Reuters) - Canada will send the armed forces and Red Cross to Ontario to help the country's most populous province as it struggles to cope with a surge in hospitalizations from COVID-19, the country's public safety minister said on Monday.

The federal government approved a request from Ontario which would include air lifting medical personnel from the Atlantic province of Newfoundland and Labrador to Toronto, the epicentre of Ontario's third wave, a spokesman from Public Safety Canada said in a statement, without giving details of personnel involved.

Bill Blair, minister of Public Safety Canada, said on Twitter the federal government has agreed to provide support to the provincial healthcare system.

Ontario reported 877 people in its intensive care units with COVID-19 on Monday. Provincial modelling showed the virus could see 1,500 people in the ICU by early May.

Alberta, which has the highest rate of COVID-19 cases in the country, said it will begin offering vaccine on Tuesday to more than 15,000 meat-packing plant workers across the province. The plants saw outbreaks of among the highest number of cases in the country during the first wave of the pandemic.

The province is also battling a surge in its northern oil sands and Premier Jason Kenney said some of the spread in infections came from workers socializing without masks in camps after work hours.

Wood Buffalo, where the oil sands are located, has the highest rate of new cases per capita in the province, with Alberta itself averaging 249 cases per 100,000 people reported in the past seven days.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Separately, Canada on Monday backed the use of Johnson & Johnson (NYSE:JNJ)'s JNJ.N Janssen COVID-19 vaccine despite reports of rare blood clots, noting the issue had first been identified in doses made by AstraZeneca (NASDAQ:AZN) PLC AZN.L .

The federal health ministry said on Twitter it "continues to consider the benefits of vaccination to outweigh these very rare potential risks, and supports the use of the Janssen and AstraZeneca vaccines."

The first Canadian deliveries of Janssen doses are due this week.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.